GlassScriptPhysician profile
Sunny K Sharma
NPI 1245526482
$1,741.38
in general payments reported to CMS, 2019-2025
19 companies · $429 in 2025
The $429 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,017 · 2020: $63.39 · 2022: $80.00 · 2023: $41.84 · 2024: $110 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $565 · Education: $15.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.17 |
| Education | $15.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $378.35 | 2019 | |
| Vertiflex, INC. | $176.67 | 2019 | |
| Depuy Synthes Sales INC. | $171.56 | 2019 | |
| Allergan, INC. | $148.79 | 2019 | |
| Integra Lifesciences Corporation | $141.51 | 2019 | |
| Intuitive Surgical, INC. | $132.01 | 2025 | |
| Lilly USA, LLC | $99.63 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Spr Therapeutics, INC | $80.00 | 2022 | |
| Novo Nordisk INC | $72.30 | 2025 | Ozempic, Wegovy |
| Abbott Laboratories | $63.10 | 2024 | Eterna |
| Intercept Pharmaceuticals, INC. | $49.05 | 2020-2023 | Ocaliva |
| Pfizer INC. | $47.71 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $40.24 | 2020 | |
| Exact Sciences Corporation | $33.76 | 2025 | The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals LP | $26.22 | 2024 | Farxiga |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.52 | 2025 | Jardiance |
| Amgen INC. | $21.66 | 2025 | Repatha, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.36 | 2025 | Relistor |
| E.R. Squibb & Sons, L.L.C. | $15.94 | 2023 | Abilify |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunny Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.